In pancreatic cancer (PC), the autocrine GDF15-GFRAL axis drives tumor growth and metastasis [96], promoting progression and therapeutic resistance through pathways involving nuclear receptor NR5A2 [97] and p38 MAPK [98]. This evidence concerns the gene GFRAL and neoplasm.